Gene polymorphisms of macrophage migration inhibitory factor affect susceptibility to chronic hepatitis B virus

Bita Moudi1,2, Zahra Heidari1,2, Hamidreza Mahmoudzadeh-Sagheb1,2

  • 1Infectious Diseases and Tropical Medicine Research Center.

Insights

The MIF-173 G/C genetic variant is associated with an increased risk of chronic hepatitis B virus (HBV) infection in Iranian individuals. This finding highlights a potential genetic predisposition to HBV infection related to the macrophage migration inhibitory factor (MIF) gene.

Area of Science:

  • Immunogenetics
  • Virology
  • Chronic disease research

Background:

  • Macrophage migration inhibitory factor (MIF) is a key proinflammatory mediator involved in chronic diseases.
  • Chronic hepatitis B virus (HBV) infection is a significant global health concern.

Purpose of the Study:

  • To investigate the association between functional polymorphisms in the MIF gene and chronic HBV infection.
  • Specifically examining MIF-173 G/C, MIF 95 bp I/D, and 189 bp I/D polymorphisms.

Main Methods:

  • Genotyping of polymorphisms using PCR-RFLP and PCR techniques.
  • Comparison of allele and genotype frequencies between 221 HBV patients and 200 healthy controls using the chi-squared test.
  • Calculation of odds ratios and confidence intervals to assess risk.

Main Results:

  • A significant difference in MIF-173 G/C genotype frequencies was observed between chronic HBV patients and healthy controls (P < 0.05).
  • Carriers of the MIF -173-C allele showed a significantly higher risk of HBV infection (P = 0.009, OR = 1.549).
  • The MIF 95 bp I/D polymorphism was not associated with chronic hepatitis, and the 185 bp I/D variant was not polymorphic in the study group.

Conclusions:

  • The MIF -173 G/C variant is suggested to increase the risk of HBV infection in Iranian subjects.
  • Further research with larger sample sizes and diverse ethnicities is needed to confirm these findings.